Orphan Drugs Market 2015-2019

2015-11-11
Price :
Published : Nov-2015
No. of Pages : 108

An orphan drug is used to treat rare diseases or disorders. According to WHO, orphan or rare diseases are the pathological conditions that affect 0.65-1 out of 10,000 population worldwide. There are around 6,000 orphan diseases, of which 80% are genetic. Orphan drugs are developed by the pharmaceutical industry to serve the public health need. These are designated as “Orphan Designations” by the regulatory agencies to accelerate the approval process.

The analysts forecast global orphan drugs market to grow at a CAGR of 10.05% over the period 2014-2019.

Covered in this report

The report covers the current scenario and the growth prospects of the global orphan drugs market for the period of 2015-2019. To calculate the market size, the report considers revenue generated from the sales orphan drugs.

The report, Global Orphan Drugs Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and Europe; it also covers the landscape of the global orphan drugs market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key regions

  • Americas
  • APAC
  • Europe

Key vendors

  • Bristol-Mayer Squibb
  • Celgene
  • F. Hoffmann La Roche
  • Novartis
  • Pfizer

Other prominent vendors

  • AbbVie
  • Actelion Pharmaceuticals
  • Alexion Pharmaceuticals
  • Alnylam Pharmaceuticals
  • Amgen
  • AstraZeneca
  • Baxter International
  • Biogen Idec
  • Celldex Therapeutics
  • Eisai
  • Eli Lilly
  • GlaxoSmithKline
  • Intercept Pharmaceuticals
  • Johnson & Johnson
  • Merck
  • NewLink Genetics
  • Northwest Biotherapeutics
  • Novo Nordisk
  • Onyx Pharmaceuticals
  • Sanofi
  • Shire
  • Synageva BioPharma
  • Takeda
  • Vertex Pharmaceuticals
  • XOMA

Market driver

  • Shorter development timelines
  • For a full, detailed list, view our report

Market challenge

  • High cost of drug development
  • For a full, detailed list, view our report

Market trend

  • Increased focus on biological drugs
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?
Filed in: Pharmaceutical
Publisher : Infiniti Research Limited
More Reports
Title Price Buy Now

Global Electronic Health Records Market 2016-2020

EHR or EMR solutions are IT solutions used to store demographic and medication-related information of people visiting hospitals for diagnosis. With the increase in the user base of personal health information devices, we expect a high demand for applications involving monitoring of health conditions without visiting hospitals. Physicians now use EHR systems to access digital patient records. The availability of cloud-based solutions facilitates the use of the latest information technologies in these systems. The increase in the use of health and fitness applications in mobile devices creates a high demand for mobile health solutions, enabling healthcare providers to improve their productivity and reduce costs of their IT infrastructure. In addition, an increase in the advanced patient care......
$2500

Global Herbal Supplements Market 2016-2020

A type of dietary supplement made of herbs, or when parts of herbs are used in supplements for scent, flavor, or potential therapeutic properties. In dietary supplements, the demand for herbal supplements is growing because of the growing demand for natural products. The analysts forecast global herbal supplements market to grow at a CAGR of 6.29% during the period 2016-2020. Covered in this report This report covers the present scenario and the growth prospects of the global herbal supplements market for 2016-2020. To calculate the market size, the report considers the revenue generated from from the sale of herbal supplements. The market is divided into the following segments based on geography: APAC Europe North America ROW The report, Global Herbal Supplements ......
$2500

Global Analgesics Market 2016-2020

Analgesics are among the most commonly prescribed drugs for pain, especially that from fractures, ankle sprains, and other injuries. These are designed particularly for pain relief. Opioids, NSAIDs, and local anesthetics are the major analgesics used to treat pain. The long term use of analgesics has been linked to gastrointestinal problems. Pain is treated with analgesics, also called as pain killers, many of which are accessible without a prescription, including acetaminophen, aspirin, or ibuprofen. These medicines are termed as non-prescription or OTC analgesics and can be used either alone for mild pain or in combination with other medicines for severe pain. The analysts forecast global analgesics market to grow at a CAGR of 4.28% during the period 2016-2020. Covered in this repo......
$2500

COPD Drugs Market in China 2016-2020

Chronic obstructive pulmonary disease (COPD) is a broad term that covers progressive lung diseases, including emphysema, chronic bronchitis, refractory (non-reversible) asthma, and some forms of bronchiectasis. It restricts airflow in the lungs and is characterized by diffculty breathing. The exact etiology of COPD is not understood, but most cases are caused due to genetic factors and by inhaling pollutants, including smoke, fumes, and chemicals. As the disease develops, the symptoms tend to get worse and damages the lungs. The disease cannot be cured, and can only be managed and treated. The COPD drugs market in China is under penetrated. It is dominated by fixed dose combinations of LABA/ICS. Air pollution is the major contributing factor for the growing prevalence of the disease. Ne......
$2500

Global Vision Care Market 2016-2020

Uncorrected refractive errors are the main cause of severe and moderate visual impairment, while eye conditions such as pink eye and cataracts (non-refractive errors) are the leading causes of blindness in middle- and low-income countries. The governments in many countries have introduced national programs and regulations to control and prevent visual impairment. Eye care services are easily available and are progressively being integrated into primary and secondary healthcare systems, which focus on the provision of high-quality services at affordable prices. For instance, Brazil has been providing eye care services through the national social security system since 2004, Morocco has been following up with the National Blindness Control Program since 1991, China has invested over 100 mi......
$2500

Global Healthcare IT Market 2016-2020

The adoption of connected healthcare solutions, such as electronic health record (EHR) and PHR, has increased with the rise in need to enhance the overall quality of healthcare services. Also, tightening of government regulations in the healthcare sector has fueled the adoption of IT solutions globally. Healthcare information technology outsourcing (ITO) solution providers will have to follow the guidelines of healthcare Acts applicable to their operating jurisdiction while delivering services. We anticipate that the high adoption of cloud computing ITO solutions and services should reduce the overall in-house IT costs. Through these solutions, healthcare providers will be able to implement business applications swiftly, while remaining focused on their core business operations. In additio......
$2500

Global Bioactive Wound Care Market 2016-2020

Bioactive wound care products play a critical role in the wound healing process and are derived from the artificial or natural sources. These products are formed by combining different polymers such as collagen, alginates, and silicon. In the past, different natural and synthetic dressings such as cotton wool, bandages, lint, and gauzes with varying degrees of absorption were utilized in wound management. However, many advanced wound care products have been introduced in the market in the last two decades. The purpose of these wound dressings is to keep the wound dry by allowing the evaporation of exudates from the surface of the wounds and restricting the entry of harmful microorganisms. The analysts forecast global bioactive wound care market to grow at a CAGR of 13.85% during the per......
$2500

rhEPO Market in China 2016-2020

Erythropoietin (EPO), also referred to as hematopoietin or hemopoietin, is a glycoprotein responsible for producing erythrocytes in the body. In the fetal stage, this protein is produced in the liver; it is secreted by the kidneys in adulthood. During anemic conditions, the body produces an excess of EPO, maintaining the normal levels of red blood cells (RBC). When the endogenous production of EPO is disturbed because of diseases or the use of medications, the normal RBC levels can be maintained by an external supply of EPO-stimulating agents (ESAs). These agents are similar to the natural EPO in structure and function and are administered as injections. They can be produced by recombinant DNA technology and are used to treat anemia due to kidney diseases, cancer, HIV, injuries, or neural ......
$2500

Global Healthcare BPO Market 2016-2020

BPO is a segment of outsourcing that consists of subcontracting business processes of an organization to a third-party vendor that has expertise in the required domain. These vendors then administer and manage the selected activity based on defined and measurable performance criteria. It helps clients increase their operational efficiency, concentrate on core competencies, reduce time-to-market, obtain access to fresh talent with experience in the latest technologies, and, in the long run, build an organization with an economical cost structure. Several healthcare providers adopt BPO services due to proven benefits of cost reduction, improved patient care services, and maximized staff efficiency. The analysts forecast global healthcare business process outsourcing (BPO) market to grow a......
$2500

Global H1N1 Vaccines Market 2016-2020

The high level of maturity in the H1N1 vaccines market has renewed the push to develop quadrivalent vaccines that address areas of the market with unmet medical needs. Vaccines that prevent H1N1 have been a long-standing void in the treatment algorithm. Therefore, the introduction advanced vaccines in the next decade will likely alter the global H1N1 vaccines market landscape. Sanofi, AstraZeneca, and VaxInnate have also invested in quadrivalent vaccines, such as Sanofi's VaxiGrip, VaxInnate's VAX2012Q, and AstraZeneca's MEDI-550 vaccine, which will impact the US and Europe markets during the forecast period. Other areas of opportunity for novel entrants include vaccines with improved immune response and immunogenic infant vaccines. The analysts forecast global H1N1 vaccines market to g......
$2500